Back
Amicus Therapeutics Stock Predictions
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
12
FOLD
Amicus Therapeutics
Last Price:
$6.22
Seasonality Move:
23.08%
7 Day Trial
ALL ACCESS PASS
$
7
Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Amicus Therapeutics Stock Forecast
-
Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 24.6% based on the past 17 years of stock performance.
-
Amicus Therapeutics has risen higher in 5 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 29.41%
-
Is Amicus Therapeutics Stock Undervalued?The current Amicus Therapeutics [FOLD] share price is $5.98. The Score for FOLD is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
FOLD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Amicus Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 24.6% based on the past 17 years of stock performance.
Amicus Therapeutics Stock Rating
Sell
12
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics overpriced?
-
Amicus Therapeutics has risen higher in 5 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 29.41%
Amicus Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com
52-Week Data
52-Week High:
12.65
52-Week Low:
5.82
Prediction Charts
Market Cap:
1.8B
Price in USD:
5.98
Volume:
8.9M
Beta:
1.01
Technical Analysis
SMA50:
7.81
SMA100:
8.68
SMA200:
9.74
52-Wk Change:
-36.92%
Stock Predictions
-
Is Amicus Therapeutics stock public?Yes, Amicus Therapeutics is a publicly traded company.
-
What is the Amicus Therapeutics stock quote today?The Amicus Therapeutics stock price is 5.98 USD today.
-
How to buy Amicus Therapeutics stock online?You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-22 | 6.79 | 6.91 | 6.92 | 6.72 |
| Apr-23 | 7.00 | 7.10 | 7.25 | 6.97 |
| Apr-24 | 7.14 | 7.20 | 7.21 | 7.01 |
| Apr-25 | 7.14 | 7.35 | 7.38 | 7.05 |
| Apr-28 | 7.35 | 7.39 | 7.41 | 7.26 |
| Apr-29 | 7.36 | 7.52 | 7.58 | 7.33 |
| Apr-30 | 7.49 | 7.68 | 7.71 | 7.37 |
| May-1 | 6.63 | 6.68 | 7.07 | 6.56 |
| May-2 | 6.69 | 6.67 | 6.80 | 6.53 |
| May-5 | 6.64 | 6.53 | 6.73 | 6.50 |
| May-6 | 6.50 | 6.19 | 6.59 | 6.14 |
| May-7 | 6.24 | 6.09 | 6.26 | 5.93 |
| May-8 | 5.98 | 6.08 | 6.26 | 5.82 |
| May-9 | 6.09 | 5.98 | 6.29 | 5.97 |
Amicus Therapeutics Earnings
Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Amicus Therapeutics Forecast Revenue Growth
Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.02 per share, an increase this year of $0.08 per share, and an increase next year of $0.47 per share.
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.